OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...

Researchers have developed a new AI system that improves lung cancer detection by analysing CT scans at both microscopic and ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...

A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...